PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
13-May-2020 Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Oral DHODH Inhibitor, IMU-838, in COVID-19 Patients Immunic, Inc.
13-May-2020 DTx Pharma Receives Prestigious Funding Award to Support Research in Neurodegenerative Diseases of the CNS DTx Pharma
13-May-2020 Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference Mylan N.V.
13-May-2020 Cardiff Oncology Enters Agreement with PoC Capital to Fund Phase 2 Clinical Trial of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Cardiff Oncology, Inc.
13-May-2020 Microsoft Grant for CoVID-19 Research to Shoolini Univ Scientists Shoolini University
13-May-2020 BerGenBio ASA: Invitation to First Quarter 2020 Results Webcast Presentation BerGenBio ASA
13-May-2020 BerGenBio ASA: Invitation to First Quarter 2020 Results Webcast Presentation BerGenBio ASA
12-May-2020 Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering Danaher Corporation
12-May-2020 Curis Reports First Quarter 2020 Financial Results Curis, Inc.
12-May-2020 Agricultural Microbials Market Worth $11.6 Billion by 2025 - Exclusive Report by MarketsandMarkets™ MarketsandMarkets
12-May-2020 GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates GRYT Health
12-May-2020 Specifica Announces Antibody Discovery Platform Transfer to Bayer Specifica
12-May-2020 Neptune Announces Launch of Neptune Air Non-Contact Thermometer Neptune Wellness Solutions Inc.
12-May-2020 Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir for COVID-19 Patients in India Glenmark Pharmaceuticals
12-May-2020 BioMarin Announces Pricing of Upsized $550 Million Senior Subordinated Convertible Notes Offering BioMarin Pharmaceutical Inc.
11-May-2020 Coronavirus (COVID-19) Update: FDA updates on surveillance inspections during COVID-19 U.S. Food and Drug Administration
11-May-2020 BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing BGI
11-May-2020 Dragonfly Therapeutics Appoints Head of Clinical Development Dragonfly Therapeutics, Inc.
11-May-2020 Protein Expression Market Worth $4.1 Billion by 2025 - Exclusive Report by MarketsandMarkets™ MarketsandMarkets
11-May-2020 TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection TolerogenixX